Celsius (NASDAQ:CELH – Get Free Report) had its price target dropped by analysts at Morgan Stanley to $65.00 in a research report issued to clients and investors on Wednesday, November 15th, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 20.04% from the company’s previous close.
Other equities analysts have also recently issued research reports about the company. Stephens boosted their price objective on Celsius from $60.00 to $66.67 in a report on Wednesday, August 9th. Wedbush restated an “outperform” rating on shares of Celsius in a report on Tuesday, November 7th. Jefferies Financial Group started coverage on shares of Celsius in a report on Monday, November 13th. They set a “buy” rating for the company. TD Cowen assumed coverage on shares of Celsius in a research note on Friday, September 15th. They issued an “outperform” rating and a $83.33 target price on the stock. Finally, Piper Sandler lifted their price target on shares of Celsius from $61.67 to $71.67 and gave the company an “overweight” rating in a research note on Tuesday, August 29th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Celsius currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.15.
Celsius Stock Performance
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings results on Tuesday, November 7th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.17 by $0.13. The company had revenue of $384.80 million for the quarter, compared to the consensus estimate of $351.54 million. Celsius had a net margin of 13.54% and a return on equity of 160.56%. The firm’s revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.24) EPS. On average, equities analysts expect that Celsius will post 0.73 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, EVP Tony Guilfoyle sold 10,190 shares of the firm’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $53.14, for a total value of $541,496.60. Following the transaction, the executive vice president now owns 234,340 shares in the company, valued at $12,452,827.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.70% of the stock is owned by insiders.
Institutional Investors Weigh In On Celsius
Hedge funds and other institutional investors have recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC increased its position in shares of Celsius by 1,350.0% during the third quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company’s stock valued at $25,000 after acquiring an additional 135 shares during the last quarter. Heritage Wealth Advisors acquired a new stake in Celsius in the 3rd quarter valued at approximately $32,000. St. Johns Investment Management Company LLC purchased a new stake in Celsius in the third quarter valued at approximately $34,000. Parkside Financial Bank & Trust acquired a new position in Celsius during the second quarter worth $30,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Celsius during the third quarter worth $36,000. 60.32% of the stock is currently owned by institutional investors and hedge funds.
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name.
- Five stocks we like better than Celsius
- What is a Special Dividend?
- $20 looks like a good fit for The Gap after XL earnings beat
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bank stocks soar with these top performers
- Why Invest in 5G? How to Invest in 5G Stocks
- Homebuilder stocks soar as sector outpaces the market
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.